Dr. Liu Jiayong
Chief physcian
He is currently the deputy director of the Department of Bone and Soft Tissue Oncology in Beijing Cancer Hospital. He graduated from the Department of Medicine of Peking University in 2007 with a clinical master's degree.
Medical Specialty
He is currently a member of the soft tissue Sarcoma Group and melanoma Group of China Anti-Cancer Association. He has been committed to the standardized treatment of soft tissue sarcoma and the surgical treatment of melanoma. The application of 99Tcm-IT-Rituximab traced sentinel lymph node biopsy in skin melanoma was first carried out in China in 2012.10. In 2010, he introduced the Clinical Practice Guide of NCCN Soft Tissue Sarcoma into China. From October 2008 to December 2012, he was a visiting scholar in the National Cancer Institute of Japan. In recent years, he published a series of papers regarding soft tissue sarcoma and melanoma in core medical journals.
Post time: Mar-04-2023